Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportMolecular Targeting Probes-Radioactive & Nonradioactive - Preclinical Probes for Oncology

New PET-radioligands for Visualization of Transient Receptor Potential Vanilloid 1 (TRPV1)

Ukihide Tateishi, Daisuke Kano, Hiroyuki Neyama, Ryutaro Kawano, Tatsuya Kida, Yilong CUI, Yasuyoshi Watanabe and Hisashi Doi
Journal of Nuclear Medicine June 2023, 64 (supplement 1) P574;
Ukihide Tateishi
1Tokyo Medical and Dental University School of Medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daisuke Kano
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hiroyuki Neyama
2Laboratory for Biofunction Dynamic Imaging, , RIKEN Center for Biosystems Dynamic Research
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ryutaro Kawano
3Genomics Unit, Keio Cancer Center, Keio University School of Medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tatsuya Kida
4Laboratory for Labeling Chemistry, RIKEN Center for Biosystems Dynamics Research
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yilong CUI
5Laboratory for Biofunction Dynamics Imaging, RIKEN Center for Biosystems Dynamics Research
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yasuyoshi Watanabe
6Laboratory for Pathophysiological and Health Science, RIKEN Center for Biosystems Dynamics Research
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hisashi Doi
4Laboratory for Labeling Chemistry, RIKEN Center for Biosystems Dynamics Research
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

P574

Introduction: Transient receptor potential vanilloid 1 (TRPV1) is an ion channel present on sensory neurons and mainly serves as a multimodal sensor of noxious stimuli which would trigger counteractive measures to avoid pain and injury. The purpose of our study was to synthesize new PET-radioligands for TRPV1 and elucidate biological evaluation of [11C]- as well as [18F]-labeled analogues.

Methods: TRPV1-targeted compounds were synthesized by modifying the structure of SB366791, a pharmaceutically representative TRPV1 antagonist, which was previously reported by Veghel DV et al. In order to avoid amide–iminol tautomerization, structurally supported N-methylated amides (i.e., 3-alkoxy-substitued N-meythylamide derivatives of SB366791) were evaluated using a Ca2+ influx assay, in which cells expressed recombinant TRPV1 in the presence of 1.0 μM capsaicin. Ehrlich Ascites Carcinoma (EAC) cells were cultivated and transplanted in subcutaneous tissue of rats. PET images of rats were reconstructed with the statistical-maximum a-posteriori probability algorithm and summated from 5 to 60 min after the bolus injection of the tracers.

Results: The antagonistic activities of N-(3-methoxyphenyl)-N-methyl-4-chlorocinnamamide (RLC-TV1004) and N-{3-(3-fluoropropoxy) phenyl}-N-methyl-4-chlorocinnamamide (RLC-TV1006) were found to be approximately three-fold higher (IC50: 1.3 μM and 1.1 μM, respectively) than that of SB366791 (IC50: 3.7 μM). Using the [11C]- or [18F]-labeled derivatives, explorative PET imaging trials were performed in rats. Biodistribution of cerebral cortex, striatum, hippocampus, thalamus, hypothalamus, liver, intestine, urinary bladder, and skin was identified (Fig). Transplanted tumor tissue could be also visualized.

Conclusions: The 3-methoxy and 3-fluoroalkoxy substituents reveals favorable radioactive [11C]methoxy- or [18F]fluoroalkoxy-incorporated tracers for visualization of in vivo PET.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 64, Issue supplement 1
June 1, 2023
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
New PET-radioligands for Visualization of Transient Receptor Potential Vanilloid 1 (TRPV1)
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
New PET-radioligands for Visualization of Transient Receptor Potential Vanilloid 1 (TRPV1)
Ukihide Tateishi, Daisuke Kano, Hiroyuki Neyama, Ryutaro Kawano, Tatsuya Kida, Yilong CUI, Yasuyoshi Watanabe, Hisashi Doi
Journal of Nuclear Medicine Jun 2023, 64 (supplement 1) P574;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
New PET-radioligands for Visualization of Transient Receptor Potential Vanilloid 1 (TRPV1)
Ukihide Tateishi, Daisuke Kano, Hiroyuki Neyama, Ryutaro Kawano, Tatsuya Kida, Yilong CUI, Yasuyoshi Watanabe, Hisashi Doi
Journal of Nuclear Medicine Jun 2023, 64 (supplement 1) P574;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Synthesis of a modified SiFA-PSMA inhibitor and its in vitro and in vivo analysis
  • Automatic Production and Preclinical Evaluation of 11C-labeled Thiolactic Acid for Cancer Imaging
  • In vivo PET imaging of 5T4 positive tumor cells using 89Zr-DFO-MY9
Show more Molecular Targeting Probes-Radioactive & Nonradioactive - Preclinical Probes for Oncology

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire